CT and MRI Diagnosis of Gallbladder Paraganglioma: A Case Analysis
-
摘要:
胆囊副神经节瘤(GB-PGL)是一类罕见的神经内分泌肿瘤,由于临床表现并无特异性,对临床医生进行诊断和治疗造成困扰。本文报道我院收治的1例经手术病理证实的胆囊副神经节瘤患者,回顾性分析该病例的影像学表现及临床资料,旨在总结出此种罕见病的CT及MRI表现,为临床胆囊肿瘤精准治疗提供帮助。
Abstract:Gallbladder paraganglioma (GB-PGL) is a rare neuroendocrine tumor that is difficult to diagnose and treat due to its non-specific clinical manifestations. In this study, we described a case of gallbladder paraganglioma confirmed by surgical pathology in our hospital. We retrospectively analyzed the associated imaging and clinical data and summarized the CT and MRI manifestations of this rare disease. Our findings may assist with the precise treatment of gallbladder tumors in clinical practice.
-
Keywords:
- tomography /
- X-ray computer /
- magnetic resonance imaging /
- gallbladder paracanglioma
-
-
表 1 胆囊副神经节瘤(GB-PGL)影像学表现
Table 1 The imaging findings of gallbladder paraganglioma
诊断要点 影像学表现 位置 好发部位依次为胆囊底部→体部→颈部 黏膜完整性 肿瘤大多起源于浆膜下结缔组织内的副神经节细胞,通常覆盖黏膜完整,不受累及 信号/密度特征 CT:平扫呈低密度,增强扫描动脉期肿瘤主体呈现不均匀明显强化,静脉期及延迟期肿瘤主体强化程度
减低,中心低密度区延迟明显强化
MRI:T1WI低信号,T2WI不均匀高信号(盐-胡椒征);增强扫描同CT增强扫描各期相似;DWI呈不均匀
高信号,与T2WI相仿血供情况 富血供,可在肿块周边见到扩张的胆囊动脉,增强后明显强化 侵及肝脏频率 较胆囊癌更易侵及肝脏,形成肝脏大面积异常灌注区,肝转移瘤特征为环形强化,弥散受限 淋巴结转移 较胆囊癌更易发生淋巴结转移 -
[1] ECE I, ALPTEKIN H, CELIK Z E, et al. Gallbladder paraganglioma[J]. Ulusal Cerrahi Dergisi, 2015, 31(4): 244−246.
[2] KOPLAY M, SIVRI M, ALPTEKIN H, et al. Gallbladder paraganglioma: Computed tomography and magnetic resonance imaging findings[J]. Prague Medical Report, 2014, 115(3/4): 145−148.
[3] SHREYA S, KASHIKAR R, SHRADDHA S R, et al. Case of the very rare gallbladder paraganglioma[J]. Indian Journal of Radiology and Imaging, 2021, 31(3): 693-696.
[4] MILLER T A, WEBER T R, APPELMAN H D. Paraganglioma of the gallbladder[J]. Archives of Surgery, 1972, 105(4): 637−639. DOI: 10.1001/archsurg.1972.04180100080019.
[5] 梁贇, 吴文铭, 聂勇战, 等. 《中国抗癌协会神经内分泌肿瘤诊治指南(2022年版)》解读[J]. 协和医学杂志, 2023, 14(1): 94−100. DOI: 10.12290/xhyxzz.2022-0607. LIANG Y, WU W M, NIE Y Z, et al. Interpretation of guidelines for the diagnosis and treatment of neuroendocrine tumor of Chinese Anti-Cancer Association (2022 edition)[J]. Union Medical Journal, 2023, 14(1): 94−100. DOI: 10.12290/xhyxzz.2022-0607. (in Chinese).
[6] ABDUL S Z, JHA A, MANDL A, et al. Gallbladder paraganglioma associated with SDHD mutation: A potential pitfall on 18F-FDOPA PET Imaging[J]. Nuclear Medicine and Molecular Imaging, 2019, 53(2): 144−147. DOI: 10.1007/s13139-018-0558-1.
[7] KIM T H, KIM S H, LEE K B, et al. Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas[J]. European Radiology, 2017, 27(2): 507−517. DOI: 10.1007/s00330-016-4394-3.
[8] BAE J S, KIM S H, YOO J, et al. Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas[J]. European Radiology, 2020, 30(5): 2890−2901. DOI:10.1007/ s00330-019-06588-9.
[9] D'JOHN M, JABBAR F. Primary gallbladder paraganglioma: A case report and review of literature[J]. International Journal Surgery Case Reports, 2020, 75: 451−453. DOI: 10.1016/j.ijscr.2020.09.095.
[10] 刘荫荣, 杨秀清, 任伟霞, 等. 胆囊神经内分泌癌的CT表现分析[J]. 医学影像学杂志, 2020, 30(8): 1437−1440. LIU Y R, YANG X Q, REN W X, et al. Analysis of the CT findings of the gallbladder neuroendocrine carcinoma[J]. Journal of Medical Imaging, 2020, 30(8): 1437−1440. (in Chinese).
[11] 谢智华, 张吉祥, 程庆保, 等. 胆囊神经内分泌肿瘤临床病理特征及预后影响因素分析[J]. 中国实用外科杂志, 2023, 43(2): 165−171. XIE Z H, ZHANG J X, CHENG Q B, et al. Analysis of clinicopathological characteristics and prognostic factors of gallbladder neuroendocrine tumors[J]. Chinese Journal of Practical Surgery, 2023, 43(2): 165−171. (in Chinese).
[12] KIM S J, LEE J M, LEE J Y, et al. Analysis of enhancement pattern of flat gallbladder wall thickening on MDCT to differentiate gallbladder cancer from cholecystitis[J]. American Journal Roentgenology, 2008, 191(3): 765−771. DOI: 10.2214/AJR.07.3331.
[13] 洪德飞. 《胆囊癌诊断和治疗指南》(2019版)解读[J]. 肝胆胰外科杂志, 2020, 32(11): 664−666. DOI: 10.11952/j.issn.1007-1954.2020.11.006. HONG D F. Interpretation of the guidelines for the diagnosis and treatment of gallbladder cancer (2019 edition)[J]. Journal of Hepatobiliary and Pancreatic Surgery, 2020, 32(11): 664−666. DOI: 10.11952/j.issn.1007-1954.2020.11.006. (in Chinese).
[14] 杨海鹏, 靳二虎, 张洁, 等. 胆囊增大的MRCP和常规MRI诊断[J]. CT理论与应用研究, 2011, 20(3): 403−414. YANG H P, JIN E H, ZHANG J, et al. MRCP with enlarged gallbladder and conventional MRI diagnosis[J]. CT Theory and Applications, 2011, 20(3): 403−414. (in Chinese).
[15] 王剑明, 何俊闯, 杨涛. 胆囊癌术前术中评估方法及价值[J]. 中国实用外科杂志, 2016, 36(10): 1029−1031. WANG J M, HE J C, YANG T. Preoperative intraoperative evaluation method and value of gallbladder cancer[J]. Chinese Journal of Practical Surgery, 2016, 36(10): 1029−1031. (in Chinese).
[16] 程浩, 石素胜. 混合性神经内分泌-非神经内分泌肿瘤组织起源的研究进展[J]. 临床与实验病理学杂志, 2021, 37(4): 446−448. CHENG H, SHI S S. Progress in the origin of mixed neuroendocrine-nonneuroendocrine tumor tissue[J]. Journal of Clinical and Experimental Pathology, 2021, 37(4): 446−448. (in Chinese).
[17] 杜倩, 梁霄, 王观宇, 等. 胆囊原发神经内分泌肿瘤5例临床特征及诊治分析[J]. 中国实用外科杂志, 2022, 42(7): 790−793. DU Q, LIANG X, WANG G Y, et al. Clinical characteristics and diagnosis and treatment of 5 primary neuroendocrine tumors of the gallbladder[J]. Chinese Journal of Practical Surgery, 2022, 42(7): 790−793. (in Chinese).
[18] 王庭俊, 谢良地. 《嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)》解读[J]. 中华高血压杂志, 2021, 29(8): 708−714. WANG T J, XIE L C. Interpretation of the expert consensus on the diagnosis and treatment of pheochromocytoma and paraganglioma (2020 edition)[J]. Chinese Journal of Hypertension, 2021, 29(8): 708−714. (in Chinese).
[19] 冯瑞颖, 刘金波. 嗜铬细胞瘤/副神经节瘤的诊疗进展[J]. 临床内科杂志, 2023, 40(4): 227−232. DOI: 10.3969/j.issn.1001-9057.2023.04.004. FENG R Y, LIU J B. Progress in the diagnosis and treatment of pheochromocytoma/paraganglioma[J]. Journal of Clinical Internal Medicine, 2023, 40(4): 227−232. DOI: 10.3969/j.issn.1001-9057.2023.04.004. (in Chinese).